Diabetes Metab Syndr
The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.
Williams DM, Parsons SN, Dunseath GJ, Stephens JW, Luzio SD, Owens DR
There is inconsistent evidence supporting the self-monitoring of blood glucose (SMBG) in people with non-insulin treated type 2 diabetes (T2D). Struct ...
Read More
Source: PubMed
Diabetes Ther 2020 Jan 24
The Effect of LM25 and LM50 on Hypoglycemia in Chinese T2DM Patients: Post Hoc Analysis of a Randomized Crossover Trial.
Li W, Ping F, Xu L, Zhang H, Dong Y, Yu K, Li Y
To investigate the safety of insulin lispro Mix 25 and 50 (LM25 and LM50) in hypoglycemia in patients with type 2 diabetes mellitus (T2DM). ...
Read More
Source: PubMed
AACE Clin Case Rep
USE OF CONTINUOUS GLUCOSE MONITORING LEADS TO DIAGNOSIS OF HEMOGLOBIN C TRAIT IN A PATIENT WITH DISCREPANT HEMOGLOBIN A1C AND SELF-MONITORED BLOOD GLUCOSE.
Wright JJ, Hu JR, Shajani-Yi Z, Bao S
Hemoglobin A1c (HbA1c) is a useful tool for the diagnosis and management of diabetes mellitus and generally an excellent marker of overall glycemic co ...
Read More
Source: PubMed
Conf Proc IEEE Eng Med Biol Soc
Reinforcement Learning-Based Adaptive Insulin Advisor for Individuals with Type 1 Diabetes Patients under Multiple Daily Injections Therapy.
Sun Q, Jankovic MV, Mougiakakou SG
The existing adaptive basal-bolus advisor (ABBA) was further developed to benefit patients under insulin therapy with multiple daily injections (MDI). ...
Read More
Source: PubMed
Expert Rev Endocrinol Metab 2020 Jan 11
Benefits and limitations of continuous glucose monitoring in type 1 diabetes.
Stone JY, Bailey TS
Introduction: Type 1 diabetes (T1D) is a chronic condition characterized by a complete deficiency in insulin production. Optimal management requires c ...
Read More
Source: PubMed
